Relationship between myocardial oxygenation and blood pressure: Experimental validation using oxygenation-sensitive cardiovascular magnetic resonance

PLoS One. 2019 Jan 16;14(1):e0210098. doi: 10.1371/journal.pone.0210098. eCollection 2019.

Abstract

Background: The relationship between mean arterial pressure (MAP) and coronary blood flow is well described. There is autoregulation within a MAP range of 60 to 140 mmHg providing near constant coronary blood flow. Outside these limits flow becomes pressure-dependent. So far, response of myocardial oxygenation to changes in pressure and flow has been more difficult to assess. While established techniques mostly require invasive approaches, Oxygenation-Sensitive (OS) Cardiovascular Magnetic Resonance (CMR) is a technique that can non-invasively assess changes in myocardial tissue oxygenation. The purpose of this study was to follow myocardial oxygenation over a wide range of blood pressure variation within and outside known coronary autoregulatory limits using OS-CMR, and to relate these data to coronary hemodynamics.

Methods: Ten anaesthetized swine (German Large White) underwent left-sided thoracotomy and attachment of a perivascular flow probe to the proximal left anterior descending (LAD) coronary artery for continuous measurement of blood flow (QLAD). Thereafter, animals were transferred into a 3T MRI scanner. Mean arterial pressure (MAP) was varied in 10-15 mmHg steps by administering alpha1-receptor agents phenylephrine or urapidil. For each MAP level, OS-CMR images as well as arterial and coronary sinus blood gas samples were obtained simultaneously during brief periods of apnea. Relative changes (Δ) of coronary sinus oxygen saturation (ScsO2), oxygen delivery (DO2) and demand (MVO2), extraction ratio (O2ER) and excess (Ω) from respective reference levels at a MAP of 70 mmHg were determined and were compared to %change in OS-signal intensity (OS-SI) in simultaneously acquired OS-CMR images.

Results: QLAD response indicated autoregulation between MAP levels of 52 mmHg (lower limit) and127 mmHg (upper limit). OS-CMR revealed a global myocardial oxygenation deficit occurring below the lower autoregulation limit, with the nadir of OS-SI at -9.0%. With MAP values surpassing 70 mmHg, relative OS-SI increased to a maximum of +10.6%. Consistent with this, ΔScsO2, ΔDO2, ΔMVO2, ΔO2ER and ΔΩ responses indicated increasing mismatch of oxygenation balance outside the autoregulated zone. Changes in global OS-CMR were significantly correlated with all of these parameters (p≤0.02) except with ΔMVO2.

Conclusion: OS-CMR offers a novel and non-invasive route to evaluate the effects of blood pressure variations, as well as of cardiovascular drugs and interventions, on global and regional myocardial oxygenation, as demonstrated in a porcine model. OS-CMR identified mismatch of O2 supply and demand below the lower limit of coronary autoregulation. Vasopressor induced acute hypertension did not compromise myocardial oxygenation in healthy hearts despite increased cardiac workload and O2 demand. The clinical usefulness of OS-CMR remains to be established.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Blood Pressure / physiology*
  • Blood Pressure Determination / methods
  • Coronary Circulation / drug effects
  • Coronary Circulation / physiology
  • Coronary Vessels / drug effects
  • Coronary Vessels / metabolism
  • Heart / diagnostic imaging
  • Image Processing, Computer-Assisted
  • Magnetic Resonance Spectroscopy / methods*
  • Models, Animal
  • Myocardium / metabolism*
  • Oximetry / methods
  • Oxygen / blood
  • Oxygen / metabolism
  • Oxygen Consumption / drug effects
  • Oxygen Consumption / physiology*
  • Software
  • Sus scrofa
  • Vasoconstrictor Agents / administration & dosage
  • Vasodilator Agents / administration & dosage

Substances

  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Oxygen

Grants and funding

This work was supported by institutional funds of the Department of Anaesthesiology and Pain Medicine at the Bern University Hospital, Inselspital, University of Bern and the Foundation for Research in Anaesthesiology and Intensive Care Medicine in Bern, Switzerland.